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ABSTRACT 
MOLECULAR MECHANISMS REGULATING COMPLEMENT RECEPTOR 3-
MEDIATED PHAGOCYTOSIS OF BORRELIA BURGDORFERI 
SEPTEMBER 2012 
KELLY L. HAWLEY 
B.S., UNIVERSITY OF MASSACHUSETTS, AMHERST 
Ph.D., UNIVERSITY OF MASSACHUSETTS, AMHERST 
Directed by: Professor Juan Anguita 
 
The macrophage receptors that mediate phagocytosis of Borrelia burgdorferi, the 
Lyme disease spirochete, are unknown despite this cell type’s importance in promoting 
pathogen clearance and inflammation-mediated tissue damage. We now demonstrate that the 
β2 integrin, Complement Receptor 3 (CR3), mediates the phagocytosis of opsonized and 
non-opsonized spirochetes by murine macrophages and human monocytes.  Although, 
expression of the surface proteins, CspA and OspE, protects B. burgdorferi from 
complement-mediated phagocytosis, the versatility of CR3 counteracts the ability of B. 
burgdorferi to interfere with complement activation and complement-derived opsonins, thus 
minimizing the bacteria’s anti-complement strategy.  Interaction of the spirochete with the 
integrin is not sufficient to internalize B. burgdorferi; however, phagocytosis occurs when 
the GPI-anchored protein, CD14, is coexpressed in CHO-CR3 cells.  CR3-mediated 
phagocytosis occurs independently of MyD88-induced or inside-out signals but requires the 
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translocation of the integrin to cholesterol rich membrane microdomains.  Interestingly, the 
absence of CR3 leads to marked increases in production of TNF in vitro and in vivo, in spite 
of reduced spirochetal uptake.  Overall, our data establish CR3 as a MyD88-independent 
phagocytic receptor for B. burgdorferi that also participates in the modulation of the 
proinflammatory output of macrophages. 
Macrophages are critical cellular components of the immune response to infectious 
agents.  During infection with B. burgdorferi, macrophages infiltrate the cardiac tissue and 
induce the activation of invariant NKT cells, leading to the production of the protective 
cytokine IFNγ.  The interaction of macrophages with infectious agents leads to the activation 
of several signaling cascades, including mitogen activated protein kinases, such as p38 MAP 
kinase.  We now demonstrate that p38 MAP kinase-mediated responses are critical 
components to the immune response during infection with B. burgdorferi.  The inhibition of 
p38 MAP kinase does not alter the ability of macrophages to phagocytose B. burgdorferi; 
however, inhibition of p38 during infection with B. burgdorferi results in increased carditis.  
Through the generation of transgenic mice that express a dominant negative form of p38 
MAP kinase specifically in macrophages, we demonstrate that this kinase regulates the 
production of the iNKT attracting chemokine, MCP-1 and the infiltration of these cells to the 
cardiac tissue during infection.  Overall, the inhibition of p38 MAP kinase during infection 
with B. burgdorferi specifically in macrophages results in the deficient infiltration of iNKT 
cells and their diminished production of IFNγ, leading to increased bacterial burdens and 
inflammation.  These results show that p38 MAP kinase provides critical checkpoints for the 
protective immune response to the spirochete during infection of the heart. 
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CHAPTER I 
INTRODUCTION 
 
Lyme disease 
In the fall of 1976, following an outbreak of juvenile rheumatoid arthritis of unknown 
origin in Old Lyme, Connecticut, an investigation was led by Yale School of Medicine’s 
Alan Steere and Stephen Malawista; the cluster of arthritis-like conditions became known as 
Lyme disease.  Willy Burgdorfer, Alan Barbour, and Jorge Benach isolated and identified the 
spirochetal bacterium, Borrelia burgdorferi, as the causative agent of Lyme disease in 1982 
(1).  Three other species of the genus Borrelia have since been identified to cause Lyme 
disease.  In the United Sates, B. burgdorferi sensu stricto is the sole etiologic agent of Lyme 
disease.  However, B. afzelii and B. garinii are restricted to Europe and Asia (Table 1.1); 
these agents of disease are collectively referred to as B. burgdorferi sensu lato.  
According to the Centers for Disease Control and Prevention, Lyme disease is the 
most common vector-borne disease in the United States.  Lyme disease commonly begins 
with an annular skin rash known as erythema migrans (EM) at the tick bite location in 70-
80% of humans within approximately 7 days of infection with B. burgdorferi (Stage I, Lyme 
disease) (2, 3).  Concurrently with the local inflammatory response, individuals may 
experience fatigue, chills, headache and muscle and joint pain (4).  If left untreated, the 
spirochete disseminates into the bloodstream and invades multiple systems and organs (Stage 
II) causing a variety of clinical symptoms.  The early dissemination stage takes place in the 
first few days to weeks post tick bite with additional EM lesions on different body areas and 
other symptoms, such as Bells’ palsy, meningitis, heart palpitation and asymmetric swelling 
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of large joints (3).  Lack of treatment may result in the late form of infection (Stage III) with 
further complications caused by damage to nerves, joints and the cardiac tissue.  It is 
believed that the pathology of the infection is the result of locally activated immune cells and 
the ensuing inflammatory response. 
 
Enzoonotic life cycle of B. burgdorferi 
Lyme disease is a zoonotic, vector borne disease where B. burgdorferi is transmitted 
by hard-bodied ticks of the Ixodes complex, particularly Ixodes scapularis and I. pacificus in 
the United States.  In addition to B. burgdorferi, I. scapularis, more commonly known as the 
black-legged tick, can act as the vector for other pathogens including Anaplasma 
phagocytophilum and Babesia microti.  The life cycle of B. burgdorferi depends intimately 
on the two-year life cycle of I. scapularis (Fig. 1.1), which consists of three developmental 
stages: larva, nymph and the adult.  The female tick lays her eggs in early spring of the first 
year, which hatch into the larvae stage during summer.  Larvae take the first blood meal by 
feeding on birds and small rodents, such as the white-footed mouse (Peromyscus leucopus) 
(5), which serve as a reservoir of the infectious agent.  Following the first blood meal, ticks 
molt into nymphs during the early fall and then lay dormant through the winter months.  In 
the late spring to early summer of the second year, nymphs quest for a second blood meal 
usually on small animals such as rodents, but also dogs and humans.  However, humans and 
dogs are not part of the enzootic life cycle of B. burgdorferi and they are considered dead-
end hosts.  Nymphs mature into adult ticks that feed a final time on large mammals, 
especially the white tailed deer, but also dogs or humans.  The final step of the life cycle can 
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be completed in the late fall or early spring; following mating, adult female ticks fall off the 
mammal and lay eggs prior to dying.  
 
The biology of B. burgdorferi 
B. burgdorferi is 0.2 to 0.3 micrometers wide, 20 to 30 micrometers in length and has 
periplasmic flagella that extend inward along the cell cylinder beneath an outer membrane 
sheath giving the spirochete a distinctive flat-wave morphology (Fig. 1.2) (6).  The unique 
rotating flagellum allows the organism to migrate to distant tissues by posteriorly 
propagating planar waves (7).  The outer membrane is essential for organism viability and 
has been extensively studied because of its importance in vaccine development and the 
induction of proinflammatory responses in the host.  The entire genomes of multiple B. 
burgdorferi strains, including the type strain B31, have been sequenced.  The unusual 
genome includes a linear chromosome approximately one megabase in size with 28.6% G+C 
content, in addition to numerous linear and circular plasmids (8).  B. burgdorferi does not 
encode for any known toxins or secretory systems, so the disease is believed to be mediated 
by the host’s inflammatory immune response to the bacteria.  More than 90% of the plasmid-
encoded genes are unique to B. burgdorferi, without homologs in any other organisms, 
suggesting that they encode proteins with functions pertinent to the distinctive lifestyle of the 
spirochete (8).  
B. burgdorferi may persist in the midgut of the tick for an extended period of time 
with limited nutrients between feedings; however, the bacteria has adapted well to surviving 
in two different environments.  Once the tick is attached to the mammalian host, spirochete 
surface protein expression is altered as a result of the increased temperature and nutrients, in 
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addition to a reduction in the pH, thus allowing the spirochetes to be transmitted to the host 
in a 40 to 48 hour time frame (9, 10).  Lipoproteins are distributed throughout the outer 
leaflet of the inner membrane (cytoplasmic membrane) and both the inner and the outer 
leaflets of the outer membrane.  Outer surface lipoprotein (Osp) A is expressed at high levels 
on the surface of the spirochete while in the unfed tick midgut and is involved in the 
attachment of B. burgdorferi to this tissue through its interaction with the receptor, TROSPA 
(11).  The down-regulation of OspA during the blood meal allows the spirochete to migrate 
to the salivary gland from where they are transmitted to the mammalian host (12).  This 
process also requires the upregulation of other genes, including those controlled by RpoS, 
such as OspC (13-16). 
 
Innate Immune Response to B. burgdorferi 
The initial detection of a pathogen by the host relies on pathogen recognition 
receptors (PRRs) and pathogen associated molecular patterns (PAMPs).  Toll receptors were 
first identified in Drosophila and later demonstrated to protect flies from fungal infections, 
bringing to light the importance of the ability of the innate immune system to recognize 
microorganisms with the aid of surface receptors (17, 18).  The mammalian homolog 
proteins were designated Toll-like receptors (TLRs) (19).  The TLR family is evolutionarily 
conserved from C. elegans to mammals and extensively characterized.  Functional assays 
revealed that TLRs were PRR with the ability to detect specific molecules such as microbial 
lipids, carbohydrates, nucleic acids and proteins among pathogens that are collectively 
referred to as pathogen-associated molecular patterns (PAMPs).  Notably, these PAMPs are 
not found in mammals thus reducing the possibility of an autoimmune mediated attack but 
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are essential for initiation of a fast immune response until a more specific response can be 
developed by the adaptive immune system.  This activation aids recruitment of innate 
immune cells and ultimately clearance of the pathogen.   
Individual microbial ligands or synthetic mimics provide valuable delineation of 
signaling events and biological responses following recognition; however this does not 
reflect the complexity of an intact microorganism.  The identification of Borrelial 
lipoproteins as PAMPs was a milestone in the understanding of macrophage response to the 
spirochete (20-25).  B. burgdorferi is recognized by several TLRs, including TLR1/2 that 
recognize triacylated proteins present in the spirochete as well as those present exclusively 
on endosomal compartments, such as TLR8 (26).  Notably, the internalization of B. 
burgdorferi greatly enhances the proinflammatory response by macrophages and changes it 
qualitatively, leading to the production of type I interferons.  TLRs recruit adaptor molecules 
such as myeloid differentiation gene 88 (MyD88) leading to the activation of signaling 
cascades that result in the production of proinflammatory cytokines (TNF, IL-12, IL-1β and 
IL-18), chemokines (MCP-1 and KC) and adhesion molecules (ICAM-1, E-selectin) as well 
as Type I interferons (27-29).  Experiments performed with MyD88 deficient mice 
demonstrated that MyD88 plays a critical role in bacterial clearance and the induction of a 
full proinflammatory response (30, 31) (32, 33). 	  All of these studies have thus demonstrated 
that MyD88 exerts a dual action during the interaction of the immune system cells with B. 
burgdorferi. 
Mitogen-activated protein (MAP) kinases are activated in response to extracellular 
stimulation of multiple triggers such as proinflammatory cytokines (e.g. TNF and IL-1β), 
TLR stimulation in a MyD88-dependent manner, as well as physical-chemical changes in the 
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extracellular milieu caused by environmental stress then modulating the activation response 
of the cell (34-39).  Several MAP kinase pathways have been described in mammals that are 
activated by phosphorylation of Thr and Tyr residues by dual-specificity kinases, specifically 
p38 MAPK is activated by MKK3 and MKK6 (34, 40-46).  B. burgdorferi is able to induce 
p38 MAP kinase activity and the kinase can control the proinflammatory response in 
phagocytic cells by regulating activation of NF-κB in a MSK1-dependent fashion (36, 47).  
P38 MAP kinase has been shown to regulate actin polymerization during cellular movement 
(which mimics to a certain extent phagocytosis), in a process that is dependent on Hsp27, a 
substrate of the kinase and the integrin activation complex component, Paxillin.  However, 
the role of p38 MAP kinase on phagocytosis and control of inflammation during infection 
with B. burgdorferi is currently unknown. 
 
Phagocytosis 
Numerous cell types interact with B. burgdorferi through PRRs other than TLRs, 
such as C-type lectins and integrins (48-50).  Integrins belong to several β groups and are 
involved in cell adhesion to a variety of ligands, in addition to cell attachment and migration.  
The recruitment of phagocytic cells to infected areas is essential for bacterial clearance and 
the modulation of the cytokine environment (51).  However, the interaction of B. burgdorferi 
with macrophages has been predominately focused on the induction of proinflammatory 
cytokines. 
Phagocytosis is defined as the internalization of particles of 1μm or larger and 
requires the initiation of specific signaling pathways that result in actin polymerization and 
the internalization of the microorganism.  Macrophages are a critical part of the response to 
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B. burgdorferi, especially for the control of spirochetal numbers in the heart that intimately 
associate with the production of the macrophage-activating cytokine, IFNγ, which enhances 
the phagocytic capacity of macrophages (51, 52).  Studies regarding the mechanism of B. 
burgdorferi phagocytosis have focused primarily on MyD88-mediated signals, including 
PI3K activity and demonstrated that a substantial amount of B. burgdorferi phagocytosis is 
MyD88-depenendent.  Nevertheless, macrophages from MyD88-deficient mice still possess 
detectable phagocytic capacity, demonstrating that MyD88 dependent and independent 
phagocytosis events are involved.  However, the phagocytic receptors involved in the 
internalization of B. burgdorferi have not been fully identified. 
 
Complement activation and bacterial opsonization 
The complement system is a complex and critical component of the innate immune 
response to pathogens.  It is comprised of serum proteins and cell surface receptors that are 
involved in the early detection of pathogens, such as B. burgdorferi (53).  Complement 
mediated destruction of organisms involves the formation of pores in the cellular membrane 
by the membrane attack complex (MAC) and results in the lysis of the organism.  
Complement activation occurs via three different pathways:  classical (antigen antibody-
mediated), lectin and alternative (pathogen surface) pathways.  All three pathways converge 
at the level of C3 convertase, which is a protease responsible for the cleavage of C3 into C3a 
and C3b.  B. burgdorferi is able to activate both the classical and alternative pathways (54), 
thus C3b can bind to the surface of bacteria and facilitate internalization of the spirochete by 
opsonization or C3b can bind C5 convertase to facilitate MAC formation and lysis of the 
bacteria by depositing downstream components into the cell wall.  B. burgdorferi  sensu lato 
group have evolved mechanisms that enable them to evade complemented-mediated lysis, 
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such as expression of complement regulator-acquiring surface proteins (CRASPs).  CRASPs 
act as binding sites for the complement inhibitor factor H and factor H-like protein (FHL-1) 
(55-57) and cleave bound serum complement protein C3b into the serum opsonin inactivated 
C3b (iC3b).  
 
Complement Receptor 3 
Complement receptor (CR) 3 also known as Mac-1 or αMβ2 integrin is a type I 
membrane glycoprotein comprised of α and β subunits, CD11b (165kD) and CD18 (95kD) 
respectively.  The heterodimeric protein is expressed on phagocytic and natural killer (NK) 
cells.  The integrin is a member of the leukocyte-restricted β2 family that shares an identical 
β subunit (CD18) that is non-covalently linked to one of four α subunits:  LFA-1 
(CD11a/CD18), CR3 (CD11b/CD18), CR4 (CD11c/CD18) and αDβ2.  αM and β2 are derived 
from nonlinked genes on the human chromosomes 16 and 21 as well as the mouse 
chromosomes 7 and 10, respectively.  CR3 acts as an intercellular adhesion molecule, in 
addition to a membrane receptor with transmembrane signaling ability.  The molecular 
structure contains two functional domains on the CD11b subunit.  At the N-terminus, an 
inserted region of 200 amino acids that is unlike the typical integrin structure is known as the 
I-domain.  ICAM-1, iC3b and fibrinogen, known CR3 protein ligands have been shown to 
interact with the I-domain of CR3 (58).  The lectin-like domain (C-lectin) is located at the C-
terminal end near the transmembrane domain of CD11b and allows the binding of 
polysaccharides from bacteria and yeast, such as filamentous hemagglutinin (FHA) of 
Bordetella pertussis and zymosan of Saccharomyces cerevisiae, promoting phagocytosis and 
cytotoxic degranulation (59).  This domain is also known to interact with GPI-anchored 
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proteins, such as CD87 (uPAR) and CD14 (60, 61). CR3 is sufficient to internalize 
microorganism and particles such as Bacillus anthracis spores in the absence of co-receptors 
(62).  Importantly, human neutrophils and Chinese hamster ovary (CHO) cells expressing 
CR3 have the ability to bind non-opsonized B. burgdorferi as well as the spirochetal outer 
surface proteins, OspA and OspB; however, the contribution to internalization of the bacteria 
remains unclear (63-65). 
Integrins, such as CR4 and CR3 are expressed on the surface of cells in a low affinity 
conformation (66, 67). Upon generation of “inside-out” signals, the transmembrane domains 
of the integrin undergo a change to a high affinity conformation (68-70).  The activation of 
CR3 changes ligand-binding specificity and affinity, which can enhance CR3-mediated 
phagocytosis. CD14 in combination with TLR2 can generate inside-out signals that result in 
the activation of CR3 (71, 72). For example, Mycobacterium bovis uptake is promoted 
through inside-out signaling, involving CD14, TLR2 and PI3K (71). Inside-out signals can 
also emanate from additional receptors, such as CD44 via the small GTPase, Rap1 (73) FcγR 
via PI3K (74) and TLRs (75).  
 
CD14 
CD14 is a 53-55 kDa glycosylphosphatidylinositol (GPI)-anchored membrane protein 
expressed on the surface of monocytes and macrophages at high levels, and on granulocytes 
at low levels.  Besides a membrane bound form, CD14 can also be present as a soluble 
protein in serum.  CD14 cooperates with several TLRs, such as TLR2, 3, 4, 7, 8 and 9 (26, 
76-78) to mediate activation of the innate immune response in response to a number of 
bacterial products other than LPS, for example, Staphylococcus aureus, Mycobacterium 
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tuberculosis and B. burgdorferi (79-83).  The role of CD14 for B. burgdorferi lipoprotein 
signaling has been extensively studied (82, 84).  However, neither TLR2 nor CD14 are 
involved in the internalization of B. burgdorferi (33, 85).  CR3 can function as a 
transmembrane signaling adaptor for GPI-anchored protein, such as CD14 and Urokinase-
type plasminogen activator receptor (uPAR), as they lack a transmembrane domain of their 
own (60, 61).  Moreover, GPI-anchored proteins have the ability to translocate receptors, like 
CR3 and TLR4 to lipid rafts (83, 86) and the disruption of the interaction results in 
diminished function (60, 87).  
 
Significance 
A large amount of research has focused on the notion that the activation of phagocytic 
cells occurs primarily via surface TLR signaling and that the response to isolated PAMPs 
mimic those elicited by whole organisms.  However, reports have demonstrated that the 
response of innate immune cells to whole microorganisms is much more complex than the 
mere sum of TLR-PAMP interactions and that both the quantity and quality of the response 
requires the phagocytosis of these microorganisms (88-92). Similarly, the induction of a 
complete proinflammatory response to B. burgdorferi requires the internalization of the 
spirochete (26, 32, 52, 93). In spite of extensive research, no phagocytic receptor has been 
identified until recently.  Our laboratory demonstrated that CR3 is a phagocytic receptor for 
B. burgdorferi.  In RAW264.7 cells, a macrophage-like cell line, a blocking mAb against 
CD11b inhibited the phagocytosis of B. burgdorferi in a dose-dependent manner.  Similarly, 
macrophages from CD11b-deficient mice showed a diminished phagocytic ability compared 
to controls.  However, when CR3 alone is expressed in CHO cells, CR3 was insufficient for 
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the internalization of B. burgdorferi and therefore, the molecular mechanisms regulating the 
phagocytosis of B. burgdorferi remain largely unknown.   
The aim of this study was to identify the mechanism by which CR3-mediated 
internalization of B. burgdorferi occurs and understand the role of MyD88 signaling on 
integrin activation and phagocytosis of the spirochete.   
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Pathogenic Species 
(B. burgdorferi senu lato) 
Tick vector Location 
B.  burgdorferi sensu stricto I. scapularis, pacificus & 
ricinus 
NE, NC, & W USA, Europe 
B. garinii I. ricinus, I. persulcatus Europe & Asia 
B. afzelii I. ricinus, I. persulcatus Europe & Asia 
 
Table 1.1.  Pathogenic Borrelia, corresponding vectors and geographic location  
 B. burgdorferi sensu lato is comprised of three genospecies of B. burgdorferi that 
causes human Lyme disease.  There are additional species of Borrelia that have been 
identified but are non-pathogenic or minimally pathogenic.  B. burgdorferi sensu stricto is 
the causative agent of Lyme disease in North America.  
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Figure 1.1. Enzoonotic cycle of B. burgdorferi  
  The life cycle of Ixodes scapularis requires two years.  The larva hatch in early 
spring and obtain their first bloodmeal by feeding on birds and small rodents, such as 
Peromyscus leucopus, which can serve as reservoirs of B. burgdorferi.  Larvae then molt into 
nymphs during late spring or early summer.  Nymphs feed on a second host, such as small 
mammals or humans, allowing the transmission of the spirochete to the mammalian host. 
Nymphs molt into adult ticks in the fall, feeding and mating on large animals such as deer. In 
early spring adult females lay their eggs to complete their two-year life cycle.  This figure is 
reproduced, with permission by Ref (94). 
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Figure 1.2. The morphological characteristics and structure of B. burgdorferi. 
 
 B. burgdorferi is a vigorously motile spirochete due to the periplasmic flagella, which 
spans the length of the spirochete between the peptidoglycan layer and outer membrane, 
originating from either end of the bacteria. (A) Freeze-fracture electron micrographs showing 
the convex and concave leaflets of the inner membrane (IM) and outer membrane (OM). 
Scale bars represent 500 nm.  (B) Cryoelectron tomograms of the ends of borrelial cells 
showing IM, OM, peptidoglycan (PG), flagellar motor and filament assemblies (FMFA), 
chemoreceptor arrays (CR) and an external layer comprising Osps. Upper scale bar 
represents 1 μm, lower scale bar represents 100 nm.  (C) Cryoelectron tomographic cross-
section showing the IM, OM, periplasmic space (PS) and periplasmic flagella (PFs). Scale 
bar represents 50 nm.  (D) Longitudinal cryoelectron tomographic slice showing a ribbon of 
nine flagellar filaments wrapping around the IM in a right-handed helix important for the 
characteristic shape of B. burgdorferi and its invasiveness into target tissues and organs by 
rotating around the protoplasmic cylinder.  Scale bar represents 200 nm. This figure is 
reproduced, with permission by Ref (94).  
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CHAPTER II 
 
CD14 COOPERATES WITH CR3 TO MEDIATE PHAGOCYTOSIS OF  
BORRELIA BURGDORFERI 
 
Introduction 
 
Phagocytosis is critical for the clearance of B. burgdorferi as well as the production 
of a robust proinflammatory response.  Studies performed in our laboratory demonstrated 
CR3 to be the first known phagocytic receptor for the spirochete; however, CR3 alone is 
insufficient to internalize B. burgdorferi.  CD14 has been demonstrated to operate as a co-
receptor with many receptors, such as TLR2 (71, 72) to enhance phagocytosis, making CD14 
an enticing candidate to cooperate with CR3 and mediate the internalization of B. 
burgdorferi.   
Results 
 
CR3 is a phagocytic receptor of Borrelia burgdorferi 
 
Since blocking of CD11b in RAW264.7 cells reduced phagocytosis of B. burgdorferi, 
we aimed to further demonstrate that CR3 is a phagocytic receptor for B. burgdorferi. We 
examined the phagocytic capacity of CD11b-deficient and wild-type bone marrow derived 
macrophages (BMMs) with increasing multiplicity of infection (m.o.i.) of GFP-expressing B. 
burgdorferi.  CD11b-deficient macrophages showed a decreased phagocytic activity 
compared to wild-type BMMs (Fig. 2.1A).  CD11b deficiency did not abrogate the capacity 
of macrophages to phagocytose B. burgdorferi, which was most evident at higher m.o.i. (Fig.  
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2.1A).  The analysis by confocal microscopy of wild-type BMM confirmed the colocalization 
of CD11b with GFP-containing phagosomes.  However, phagosomes with spirochetes that 
did not contain the integrin were also evident (Fig. 2.1B).  These data demonstrate that CR3 
is the first identified phagocytic receptor for B. burgdorferi and that additional unidentified 
receptors also participate in the internalization of the spirochete. 
We next preformed an in vivo phagocytosis assay (95). We injected 107 spirochetes 
intraperitoneally into CD11b-deficient and wild-type mice.  The infiltrating cells were 
collected by peritoneal lavage after 6 hours, stained for F4/80, a macrophage specific marker, 
and analyzed by flow cytometry. CD11b-deficient macrophages contained lower levels of 
GFP-expressing B. burgdorferi than wild-type cells (Fig. 2.1C). The difference observed was 
not due to a defect in macrophage migration to the injection site because the percentage of 
F4/80+ cells did not vary between wild-type and CD11b-deficient mice (21.1% ± 1% and 
20.2% ± 3.1% respectively).  Together these data demonstrate that CR3 is a phagocytic 
receptor for B. burgdorferi.  
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Figure 2.1.  CR3 deficiency results in diminished phagocytosis of B. burgdorferi.  
(A) Phagocytosis of Bb914 by BMMs generated from CD11b-deficient mice (blue 
histogram) or B6 controls (black histogram). The 4 °C binding control is represented by the 
grey histograms. The cells were tested at m.o.i. of 1 (top graph) and 10 (bottom graph).  (B) 
Confocal micrograph of a wild type BMM showing colocalization of Bb914 (green) and 
CD11b (blue). The small panels represent internalized B. burgdorferi (arrows) that displayed 
presence or absence of colocalization with CD11b.  (C) In vivo phagocytosis of B. 
burgdorferi by CD11b-deficient and wild-type B6 mice injected intraperitoneally with 107 
spirochetes. A B6 mouse was also injected with non-GFP (WT) B. burgdorferi to control for 
migration of inflammatory cells into the peritoneum. The peritoneal lavages were analyzed 
after 6 h by flow cytometry. Shown are representative results for a total of three CD11b-
deficient and three control B6 mice. 
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Complement enhances phagocytosis of B. burgdorferi in a C3-dependent manner 
The previous results were performed in the absence of active complement, indicating 
that CR3 is able to directly interact with B. burgdorferi antigens and mediate its 
phagocytosis. However, the alternative and lectin complement pathways can enhance 
phagocytosis by coating the surface of bacteria with opsonins, such as iC3b.  Since CR3 
binds iC3b and mediates the opsonization-dependent phagocytosis of microorganisms, we 
investigated the role of complement-mediated opsonization in the phagocytosis of B. 
burgdorferi. We incubated RAW264.7 cell with 10% C3-deficient serum (C3-/-) or active 
normal mouse serum (NMS) and GFP-expressing B. burgdorferi.  The presence of normal 
serum significantly enhanced the phagocytic uptake of the spirochete in a C3-dependent 
manner, since C3-/- serum did not enhanced the phagocytic capacity of RAW cells (Fig. 
2.2A & 2.2B).  These results were confirmed using primary macrophages obtained from 
wild-type mice (Fig. 2.2A & 2.2B).  Additional experiments performed in our lab, in which 
CD11b was blocked with a specific mAb (clone: M1/70), reduced serum-mediated 
enhancement to the same level as cells in the absence of serum (data not shown), 
demonstrating that the increased phagocytosis observed in the presence of sera was CR3 
dependent. Our results indicate that complement-mediated opsonization of B. burgdorferi is 
able to increase the phagocytosis by macrophages dependent on the serum factor C3. 
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Figure 2.2.  Normal, but not C3-deficient sera, increases the phagocytosis of B. 
burgdorferi by macrophages. 
 
(A) RAW264.7 cells and (B) BMMs were incubated with GFP B. burgdorferi at an 
m.o.i. of 25 for 6 h, in the presence of heat-inactivated (black histogram), normal (red 
histogram) and C3-deficient mouse sera (green histogram).  The gray histogram indicates the 
4°C binding control. Cells were analyzed by flow cytometry (left panel); calculated MFI of 
GFP and values expressed in a bar graph (right panel). The results are the average ± SE of 
one experiment and is representative of two performed in triplicate.  *, Student’s t test, p < 
0.05 and  **, Student’s t test, p <0.001.  
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CspA and OspE protect against serum-mediated phagocytosis 
 
B. burgdorferi is capable of disseminating and persisting in various tissues of the host 
suggesting that B. burgdorferi has developed mechanisms to evade innate immune responses.  
B. burgdorferi lipoproteins, CspA, CspZ and OspE-related proteins are collectively referred 
to as complement regulator-acquiring surface proteins (CRASPs) and have been shown to 
bind Factor H (FH) and FH-like proteins (55, 56, 96), which are negative regulators of the 
alternative complement pathway.  Both CspA and OspE inhibit complement to evade 
spirochetal killing (97, 98).  However, CspZ is not exposed to the surface and is not required 
for serum resistance or infection (99).  To elucidate the contribution of CspA in the serum-
mediated phagocytosis of the spirochete, we utilized a GFP-expressing B31 stain of B. 
burgdorferi in which cspa was interrupted by insertion of a streptomycin resistance cassette. 
BMMs from B6 mice were incubated with the CspA mutant (CspA-) spirochete, 10% HI or 
NMS and analyzed by flow cytometry.  The cspa gene was complemented (CspA +) to 
confirm that the phenotype observed was the result of the loss of the lipoprotein encoded by 
cspa.  The uptake of the CspA- spirochetes was significantly higher than CspA+ B. 
burgdorferi in the presence of 10% NMS (Fig 2.3A & 2.3B).  However, there was no 
difference between the two strains of spirochetes when incubated with 10% HI serum (Fig.  
2.3A).  Moreover, the phagocytic capacity of human monocytes (hMon) was significantly 
higher for the mutant spirochete (Fig 2.3C).  These data demonstrate that B. burgdorferi 
CspA protects the spirochete from serum-mediated phagocytosis. 
We also evaluated the contribution of B. burgdorferi outer surface protein E (OspE) 
in opsonin-mediated phagocytosis. OspE was overexpressed in CspA-deficient spirochetes 
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(100).  BMM and hMon were cultured with 10% heat inactivated or active serum. The 
overexpression of OspE resulted in a significant reduction in the ability of both BMMs and 
human monocytes to phagocytose the spirochete, compared to spirochetes containing the 
vector control (Fig 2.4A & 2.4B); these results show that both CspA and OspE allow the 
spirochete to evade complement-mediated opsonization and phagocytosis.  
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Figure 2.3.  CspA protect against serum-mediated phagocytosis. 
(A) BMMs were incubated with the GFP-expressing B. burgdorferi B31 CspA mutant 
(red histogram) or the CspA complement (black histogram), in the presence of heat-
inactivated (top panel) or 10% normal mouse sera (bottom panel).  The experiments were 
performed at an m.o.i. of 25 and a 4 h period of incubation.  (B) BMM and (C) hMon 
phagocytic capacity for CspA mutant and complement B. burgdorferi with 10% active mouse 
or human sera, respectively, were represented by the MFI of GFP.  *, Student’s t test, p < 
0.05. 
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Figure 2.4.  Expression of OspE reduces serum-mediate phagocytosis of B. 
burgdorferi. 
CspA-deficient, GFP B. burgdorferi B31 containing a plasmid control (gfp-pSP1G) 
or complemented with the ospE gene (OspE-gfp-pSP1G) were used in phagocytosis assays at 
an m.o.i. of 25 for 4h with (A) BMMs or (B) hMon in the presence of heat inactivated or 
active sera.  The active serum MFI was normalized to the HI serum MFI to account for the 
different levels of GFP expression by both strains (data not shown).  The results are the 
average ± SE of one experiment and is representative of two experiments performed in 
triplicate.  **, Student’s t test, p <0.001.  
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CD14 cooperates with CR3 during phagocytosis of B. burgdorferi 
 
Studies preformed in our laboratory demonstrated that CHO cells stably expressing 
human CR3 lack the ability to internalize B. burgdorferi.  These results could be the result of 
a functional defect of the ectopically expressed CR3 or because CR3-dependent phagocytosis 
of B. burgdorferi requires a co-receptor.  To evaluate the phagocytic ability of CHO-CR3 
cells, we incubated the cells with zymosan488 particles, which only require CR3 for 
internalization (101).  The cells were analyzed by Apotome fluorescence microscopy to 
confirm that the ectopically expressed CR3 in the CHO cell line is functional and the cells 
possess phagocytic capacity (Fig. 2.5A).  Therefore, our results implied that CR3 requires a 
co-receptor for the phagocytosis B. burgdorferi.  The GPI-anchored protein, CD14 has been 
shown to enhance CR3-mediated phagocytosis of several pathogens and particles such as 
Bacillus anthracis spores and Mycobacterium kansasii (62, 102).  We utilized a CHO-CR3 
cell line expressing CD14 (CHO-CR3/CD14) (103) to analyze their phagocytic capacity 
against B. burgdorferi.  CHO-CR3/CD14 cells were readily able to phagocytose the 
spirochete (Fig. 2.5A) in a CR3-dependent manner, since preincubation with the mAb M1/70 
resulted in the reduced uptake of B. burgdorferi when compared to cells incubated with the 
isotype control (Fig. 2.5B). 
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Figure 2.5.  CD14 cooperates with CR3 to promote phagocytosis of B. burgdorferi. 
 
(A) CHO-CR3 and CHO-CR3-CD14 cells were grown in eight-well chamber slides 
and incubated with Zymosan labeled with Alexa Fluor 488 (m.o.i. = 5) or Bb914 (m.o.i. = 
25) for 4 h.  The cells were washed, fixed, permeabilized and stained with phalloidin Alexa 
Fluor 594, followed by analysis by Apotome fluorescence microscopy.  (B) CHO-CR3/CD14 
cells grown in chamber slides were incubated with Bb914 (m.o.i. = 25) for 4 h in the 
presence of M1/70 mAb or an isotype control.  The cells were fixed, stained with phalloidin 
Alexa Fluor 594 and analyzed by confocal microscopy. 
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CD14 does not contribute to the binding of B. burgdorferi 
 
To investigate whether CD14 cooperates with CR3 by participating in the binding of 
B. burgdorferi, we incubated CHO-CR3 and CHO-CR3/CD14 cells with increasing m.o.i. of 
spirochetes and analyzed their binding capability by flow cytometry.  The two cell lines were 
able to bind the bacteria equally (Fig. 2.6A).  We next pretreated CHO-CR3/CD14 cells with 
10μg/ml of the human CD14 blocking antibody or an isotype control (104) and flow 
cytometry was used to compare the internalization of the spirochetes (Fig 2.6B).  Treatment 
with the blocking antibody resulted in no difference in the CHO-CR3/CD14 cells ability to 
phagocytose B. burgdorferi when compared to the cells treated with the isotype control.  We 
verified these results using a mouse-specific antibody and RAW264.7 cells (Fig. 2.6C).  
These data indicate that CD14 does not contribute to the binding of B. burgdorferi. 
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Figure 2.6.  CD14 does not contribute to B. burgdorferi binding. 
 (A) CHO-CR3 (open circles) and CHO-CR3/CD14 (solid circles) were incubated 
with increasing m.o.i. of Bb914 and then analyzed by flow cytometry.  (B) CHO-CR3/CD14 
(top panel) and RAW264.7 (bottom panel) were pre-incubated with 10μg/ml of CD14 
blocking antibody (Red histogram) or isotype control (Black histogram), then Bb914 (m.o.i. 
= 25) for 4 h and analyzed by flow cytometry.  (A) The results represent the mean percentage 
of GFP+ cells ± SE for three independent experiments.  (B) The results are representative of 
two independent expreiments performed in triplicate. 
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CR3-mediated phagocytosis of B. burgdorferi requires its translocation to the lipid rafts  
CD14 is present in cholesterol rich domains on the plasma membrane and induces the 
specific assembly of additional receptors to initiate signaling cascades (85, 105).  Our results 
suggested that CD14 interacts with CR3 during B. burgdorferi phagocytosis (Fig 2.7A).  We 
confirmed the colocalization of CD11b and CD14 by confocal microscopy in BMMs in the 
presence as well as the absence of B. burgdorferi (Fig. 2.7A).  To assess whether CR3 
translocates to membrane microdomains upon interaction with B. burgdorferi, we performed 
a sucrose density gradient assay with RAW264.7 cells that had been incubated with B. 
burgdorferi at an m.o.i. of 25.  The gradient was fractionated, precipitated and analyzed by 
immunoblotting.  CD11b co-localized with CD14 in the lipid raft fractions of the gradient 
regardless of the activation status of the cells.  However, we observed a degree of CD14 
reorganization and an increased level of the protein upon stimulation with B. burgdorferi 
(Fig. 2.7B).   
Lipid rafts are rich in ganglioside GM1 that readily bind cholera toxin subunit B 
(CTxB) making it a useful method for their detection (106).  We analyzed CD11b and CTxB 
staining by confocal microscopy in RAW264.7 cells in the presence or absence of B. 
burgdorferi.  CD11b colocalized with CTxB under both conditions (Fig. 2.7C).  Moreover, 
B. burgdorferi were attached to the surface of the macrophage in lipid rich regions stained 
with CTxB (Fig. 2.7C).  
To determine the contribution of lipid rafts to the internalization of B. burgdorferi, we 
analyzed RAW264.7 cell phagocytic ability in the presence and absence of methyl-β-
cyclodextran (MβCD), a lipid-sequestering compound that disrupts the cholesterol 
component of the lipid rafts (107).  RAW264.7 cells were incubated with 5mM MβCD, a 
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concentration that does not affect cell viability, prior to the phagocytosis assay.  The 
disruption of lipid rafts revealed a partial reduction in the phagocytic capacity of RAW264.7 
cells (Fig. 2.7D).  CHO-CR3/CD14 cells were also treated under the same conditions, which 
resulted in an almost complete abrogation of B. burgdorferi internalization (Fig. 2.7D).  
These data indicate that CR3 phagocytosis requires the translocation of CR3 to membrane 
microdomains. 
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Figure 2.7.  CR3-mediated phagocytosis of B. burgdorferi requires the translocation of 
the integrin to lipid rafts. 
 
(A) Co-localization of CD11b and CD14 in BMMs stimulated with Bb (m.o.i.= 10) or 
cells that were left unstimulated.  The cells were incubated with Bb for 1 h, fixed and stained 
with anti-CD14 (red) and anti-CD11b (blue) Abs.  Co-localization of CD14 and CD11b is 
noted in purple.  Triple co-localization with GFP is shown in white. (B) RAW264.7 cells 
were incubated for 1 h with Bb (m.o.i. = 25), lysed and layered onto a sucrose gradient.  The 
gradients were separated by ultracentrifugation for 20 h following which 10 fractions of 100 
µl were collected.  The fractions were precipitated with tricholoroacetic acid, run on a SDS-
PAGE, transferred to nitrocellulose membranes and immunoblotted with anti-CD11b and 
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anti-CD14 Abs.  Fraction numbers from the top are indicated.  T: whole lysates (25 µg). (C) 
Confocal micrographs showing CD11b localization to lipid rafts.  RAW264.7 cells were 
incubated with Bb914 (lower panels) or left unstimulated (upper panels) for 30 min.  The 
cells were washed, fixed and stained with an anti-CD11b Ab (blue) and CTxB (red).  
Colocalization of CD11b and CTxB staining is indicated by the purple color in the small 
panel.  (D) RAW264.7 cells (Top panel) or CHO-CR3/CD14 (Bottom panel) were 
preincubated with 5 mM of MβCD (red histogram), followed by incubation with Bb914 
(m.o.i. = 25) for 2 hours.  The cells were then analyzed by flow cytometry.  Control cells 
(black histogram) were left untreated.  The results presented are representative of 3-5 
individual experiments. 
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Engagement of the C-Lectin domain in CR3 is sufficient to internalize B. burgdorferi 
CR3 contains an I-domain that binds to opsonized bacteria and a C-lectin domain that 
can bind sugars such as β-Glucan and GPI-anchored proteins.  To assess whether CR3 
crosslinking upon engagement of the C-lectin domain was sufficient for the phagocytosis of 
B. burgdorferi, we evaluated the involvement of the C-lectin domain on the uptake of the 
spirochete.  RAW 264.7 cells were incubated with B. burgdorferi (m.o.i. = 25) and β-Glucan 
from different origins for 4 hours.  The treatment with S. cerevisiae β-Glucan enhanced the 
phagocytosis of the spirochetes (Fig. 2.8A) suggesting that interaction with the C-lectin 
domain may be sufficient for CR3 crosslinking and phagocytosis.  
We also treated CHO-CR3 cells lacking CD14 with S. cerevisiae β-Glucan during 
incubation with B. burgdorferi (m.o.i. = 10) and analyzed the cells by confocal microscopy.  
We observed that the bacteria were internalized in the same manner as the CHO-CR3/CD14 
cells (Fig. 2.8B).  These data show that CR3-mediated phagocytosis of B. burgdorferi 
requires the engagement of the C-lectin domain of the integrin. 
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Figure 2.8.  Engagement of C-lectin domain is sufficient to internalize B. burgdorferi. 
(A) RAW264.7 incubated with 1mM barley β-Glucan orange histogram), Laminarin 
β-Glucan (green histogram) and S. cerevisiae β-Glucan (red histogram) and Bb914 (m.o.i. = 
25) for 4 hours.  The control cells (black histogram) were incubated with Bb914.  (B) CHO-
CR3 cells were incubated with 1mM S. cerevisiae β-Glucan and Bb914 for 4 hours.  The 
cells were fixed, stained with phalloidin Alexa Fluor 594 and analyzed by confocal 
microscopy.  The results presented are representative of 3 experiments preformed in triplicate. 
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Infection of CD11b-deficient mice results in increased cardiac inflammation and 
deficient bacterial control  
Macrophages are critical for bacterial clearance and proinflammatory cytokine 
production.  Our laboratory has demonstrated that macrophages deficient in CD11b have 
reduced ability to phagocytose B. burgdorferi.  Given the importance of CR3 in bacterial 
phagocytosis (61-63, 71, 102), we assessed the contribution of CR3 during infection with B. 
burgdorferi.  Wild type C57Bl/6 (WT) mice and CD11b-deficient C57Bl/6 (CD11b -/-) mice 
were subcutaneously injected with B. burgdorferi strain 297 and analyzed at 2 weeks of 
infection.  Arthritis and carditis severity were evaluated by H&E histological analysis. 
CD11b-deficient mice developed similar levels of arthritis as wild type controls (Fig 2.9B).  
However, carditis severity in CD11b-deficient mice was significantly increased compared to 
controls (Fig. 2.9A).  The lack of CD11b resulted in a significant increase in the percentage 
of infected hearts (Fig. 2.9C), as well as the geometric mean of the number for bacteria per 
infected heart (WT: 24, CD11b-deficient: 174 copies of spirochetal recA per copy of murine 
actin).  These results showed that CR3 is critical for pathogen control and disease severity 
during infection with B. burgdorferi. 
CD11b has been shown to be a negative regulator of TLR-triggered proinflammatory 
cytokines, such as TNF, involving the degradation of MyD88 and TRIFF by the E3 ubiquitin 
ligase (108).  To determine whether the loss of the β2 integrin plays a role in the in vivo 
proinflammatory response to B. burgdorferi infection, we analyzed tnf gene expression from 
the cardiac tissue of infected mice by isolating total RNA for qRT-PCR.  We observed that 
the levels of cytokine transcript were significantly increased in the absence of the integrin 
compared to wild type mice (Fig. 2.10A).  These results correlated with the increased TNF 
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production by CD11b-deficient macrophages in response to B. burgdorferi stimulation 
compared to controls (Fig. 2.10B), (52).  This response mimicked the increased cytokine 
production in response to the spirochete observed in CD14-deficient mice (109) and strongly 
supports a model in which GPI-anchored proteins cooperate with CR3 in the internalization 
of the spirochete and the modulation of cytokine expression in response to B. burgdorferi. 
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Figure 2.9.  Lyme carditis in CD11b-deficient mice involves deficient control of B. 
burgdorferi. 
CD11b-deficient and wild-type controls were infected with 105 spirochetes by s.c. 
injection in the midline of the back.  (A and B) After being euthanized, the mice were 
analyzed histologically for signs of arthritis (B) and carditis (A and B).  *Student’s t test, p < 
0.05. n = 11 in each group.  (C) Percentages of hearts positive for B. burgdorferi recA targets 
by qPCR. *χ2, p < 0.05. n = 16 in each group.  
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Figure 2.10.  CD11b modulates the proinflammatory cytokine, TNF. 
(A) The levels of tnf gene expression in the hearts of the infected mice were analyzed 
by qRT-PCR relative to actin levels.  *Student’s t test, p < 0.05. n = 11 in each group.  The 
results represent two to three independent experiments with 5–6 mice per group.  (B) TNF 
production by B6 and CD11b-deficient BMMs in response to B. burgdorferi stimulation.  
BMMs were stimulated with live spirochetes at increasing m.o.i. for 16 hours, followed by 
the analysis of the stimulation supernatants for TNF by ELISA. 
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CHAPTER III 
THE ACTIVATION OF CR3 ENHANCES PHAGOCYTOSIS OF BORRELIA 
BURGDORFERI AND IS INDEPENDENT OF MYD88-INDUCED SIGNALS 
 
Introduction 
 
Inside-out signals can emanate from a variety of receptors such as CD14/TLR2 (71, 
72) and induce the activation of integrins, like CR3.  The conformational change to the 
integrin can enhance ligand affinity and increase phagocytosis.  However, the involvement of 
integrin activation in response to B. burgdorferi has yet to be studied.  Additionally, MyD88 
signaling is partly required for phagocytosis of B. burgdorferi (33, 110) even though the 
signaling receptors, TLR2 and CD14 are not involved in the internalization of the spirochete 
(33, 85), which suggests that both MyD88-dependent and independent pathways contribute 
to spirochetal uptake by macrophages. 
 
Results 
 
Activation of CR3 enhances, but is not required for, B. burgdorferi uptake  
 
Integrins, including CR3, are present on the cell surface in a low affinity 
conformation but can undergo conformational changes that lead to an increase in ligand 
affinity (111).  Inside-out signals can stem from CD14/TLR2 engagement as well as other 
receptors such as CD44 or Fc receptors.  To identify whether B. burgdorferi induces CR3 
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activation, we used an antibody clone (CBRM1/5) that specifically binds to the high-affinity 
conformation of the integrin.  The incubation of RAW264.7 cells with live B. burgdorferi or 
1μM Mn2+ resulted in the increased binding of the CBRM1/5 mAb (Fig. 3.1A).  We next 
determined if the activation of CR3 with Mn2+ enhances the RAW264.7 cells’ ability to 
phagocytose B. burgdorferi.  We observed a dose-dependent increase in internalized 
spirochetes with the activation of CR3 by Mn2+ (Fig. 3.1B).   
We then addressed the effect of B. burgdorferi stimulation on CR3 affinity in CHO-
CR3 and CHO-CR3/CD14 cells.  In both cases, the stimulation with B. burgdorferi failed to 
increase binding of CBRM1/5, while Mn2+ induced the expected conformational change in 
CR3 (Fig. 3.1C).  These data show that the activation of CR3 although not required, can 
enhance the internalization of B. burgdorferi. 
  
	   40	  
 
Figure. 3.1.  Inside-out signals are not required for the phagocytosis of B. burgdorferi. 
 
(A) RAW264.7 cells were incubated with Bb914 (m.o.i. = 25, green histogram) or 
MnCl2 (1 μM, red histogram), washed and stained with the mAb CBRM1/5.  The cells were 
fixed and analyzed by flow cytometry.  (B) RAW264.7 cells were incubated with increasing 
concentrations of MnCl2 (0.5 μM, orange histogram; 1 μM, red histogram) or left 
unstimulated (black histogram), washed and assessed for their phagocytic activity using 
Bb914 (m.o.i. = 25).  (C) CHO-CR3 (upper) and CHO-CR3/CD14 cells (lower) were 
incubated with Bb914 (green histograms) or MnCl2 (red histograms), as before.  The cells 
were stained with the mAb CBRM1/5, fixed and analyzed by flow cytometry. 
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MyD88-signals are not required for CR3-mediate phagocytosis or integrin activation 
 
Phagocytosis of B. burgdorferi is partly dependent on MyD88 and PI3K signals 
(110).  However, CHO cells lack a functional TLR2 (112), which suggests that the 
internalization of B. burgdorferi mediated by CR3 is independent of MyD88 signals.  To 
evaluate the role of MyD88 signals in CR3-mediate phagocytosis of B. burgdorferi, we 
assessed the uptake of the spirochete by CHO-CR3/CD14 cells pretreated with a membrane-
permeable MyD88-blocking peptide.  The blocking peptide did not affect the internalization 
of B. burgdorferi by CHO-CR3/CD14 cells in comparison to RAW264.7 cells (Fig. 3.2A).   
These results were confirmed by confocal microscopy (Fig. 3.2B). 
To investigate the role of MyD88-derived signals on integrin activation, we pretreated 
RAW264.7 cells with the MyD88-blocking peptide followed by stimulation with B. 
burgdorferi.  The inhibition of MyD88 did not affect the activation of CR3 in response to the 
spirochete (Fig. 3.2C), suggesting that MyD88 signals are not involved in inside-out 
signaling leading to the activation of CR3. 
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Figure 3.2.  CR3-mediate phagocytosis of B. burgdorferi is MyD88-independent. 
 (A) Flow cytometric analysis of phagocytosis by CHO-CR3/CD14 (bottom panel) 
and RAW264.7 cells (top panel) in the presence of MyD88-BP (red histograms) or the 
control peptide (black histograms).  The cells were pre-incubated with the peptides at 50 µM 
for 1 h, prior to adding Bb914 (m.o.i. = 25).  (B) Confocal images of B. burgdorferi 
phagocytosis by CHO-CR3/CD14 cells in the presence of a blocking MyD88 peptide.  
Chamber-grown cells were incubated with 50 µM of the blocking MyD88 peptide (MyD88-
BP) or a peptide control (MyD88-CP) for 1h, followed by incubation with Bb914 for 4 hours.  
The cells were then washed, fixed and stained with phalloidin- Alexa fluor 594.  (C) 
RAW264.7 cells were preincubated with the peptides at 50 µM for 1 h MyD88-BP (red 
histogram) or the control peptide (green histogram), prior to adding Bb914 (m.o.i. = 25) 
Bb914 for 15 mins, then washed and stained with the mAb CBRM1/5.  The cells were fixed 
and analyzed by flow cytometry. 
 
  
MyD88-CP MyD88-BP 
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CR3-mediated phagocytosis of B. burgdorferi is independent of PI3K signals 
We analyzed the uptake of B. burgdorferi by CHO-CR3/CD14 cells in the presence 
of the PI3K inhibitors, LY294002 and wortmannin.  The presence of either inhibitor did not 
affect the ability of CHO-CR3/CD14 cells to phagocytose B. burgdorferi (Fig. 3.3); however, 
RAW264.7 cells (Fig. 3.3) exhibited a diminished bacterial uptake in the presence of both 
inhibitors, as reported (110). Together these data show the in CHO cells, CD14 cooperates 
with CR3 independently of TLR2 and MyD88-derived signals, including PI3K activity.   
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Figure 3.3.  CR3-mediated phagocytosis of B. burgdorferi is independent of PI3K 
signals. 
 
Flow cytometric analysis of phagocytosis by CHO-CR3/CD14 (left histograms) and 
RAW264.7 cells (right histograms).  The cells were preincubated with the PI3K inhibitors, 
LY294002 (10 µM) and wortmannin (2 µM) (red histograms) or DMSO (control, black 
histograms).  The cells were incubated with the inhibitors for 1 h, followed by Bb914 (m.o.i 
= 25).  Phagocytosis was allowed to proceed for 4 h.  The results are representative of at least 
3 experiments performed in triplicate. 
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CR3 activation and CR3-mediated phagocytosis of B. burgdorferi is independent of 
Rap1 signals 
CD44 has been shown to induce inside-out activation of CR3 via the small GTPase, 
Rap1 (73).  However, when we incubated RAW264.7 cells with a CD44 blocking antibody, 
there was no difference in phagocytosis of B. burgdorferi when compared to isotype-treated 
controls (data not shown) demonstrating that CD44 does not play a role during the 
phagocytosis of B. burgdorferi.  We further investigated the potential role of Rap1 in the 
activation of CR3. RAW267.4 cells were pretreated with the Rap1 inhibitor, GGTI-298 or 
DMSO, and stimulated with B. burgdorferi.  The inhibition of Rap1 did not affect the 
binding of the high affinity specific antibody, CBRM1/5 to the B. burgdorferi stimulated 
RAW264.7 cells (Fig. 3.4A), demonstrating that Rap1 does not mediate the activation of 
CR3.  However, RAW264.7 cells treated with the inhibitor displayed a reduction in their 
phagocytic capacity against B. burgdorferi, compared to DMSO-treated controls (Fig. 3.4B).  
Importantly, CHO-CR3/CD14 cells incubated with GTTI-298 readily internalized B. 
burgdorferi to similar levels as the controls (Fig. 3.4C).  Furthermore, RAW264.7 cells 
treated with GGTI-298 secreted a significantly lower level of TNF (Fig. 3.4D).  These results 
showed that Rap1 regulates the phagocytosis of B. burgdorferi independently of CR3. 
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Figure 3.4.  Rap1 signaling does not induce activation of CR3 and participate in CR3-
mediated phagocytosis of B. burgdorferi. 
(A) RAW264.7 cells were pre-incubated with GTTI-298 then incubated with Bb914 
(m.o.i. = 10, green histogram) or DMSO (red histogram), washed and stained with the mAb 
CBRM1/5.  The cells were fixed and analyzed by flow cytometry (B) RAW264.7 cells (C) 
CHO-CD3-CD14 cells were preincubated with 20μM GTTI-298 (red histogram) or DMSO 
(black histogram) then with Bb914 (m.o.i. = 25) for 6 hours.  (D) Supernatants from 
experiments in B were analyzed by ELISA for TNF production. 
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B. burgdorferi phagocytosis is independent of p38 MAP kinase activity 
p38 MAP kinase activity has been suggested to be involved in phagocytic events and 
the maturation of the phagosome (113).  To assess the role of p38 in phagocytosis of B. 
burgdorferi, we generated transgenic (Tg) mice with repressed p38 activity in macrophages 
through overexpression of a dominant negative form of the kinase (Fig. 3.A) (114).  BMMs 
generated from the Tg mice internalized GFP-expressing B. burgdorferi as efficiently as 
normal litter control (NLC) macrophages (Fig. 3.5B), indicating that the transgene did not 
affect the ability of the macrophage to eliminate the spirochete by phagocytosis.  The cell 
surface protein levels of CD11b on BMMs of the Tg mice and NLC were identical (Fig. 
3.5C).  These results demonstrate that internalization of B. burgdorferi by macrophages does 
not require p38 MAP kinase activity. 
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Figure 3.5.  p38 MAP kinase does not regulate phagocytosis of B. burgdorferi. 
(A) Schematic representation of the dnp38 MAP kinase gene used to generate the 
transgenic mice (top) showing the promoter (cd11b), the dnp38 gene, followed by the human 
growth hormone polyA/intron signal sequence.  The arrows represent the localization of the 
primers used to detect mRNA expression in different tissues (Fig. 3.6A) plus bone marrow-
derived macrophages.  Primers for actin were used as control.  (B) Phagocytosis of GFP-
expressing B. burgdorferi by Tg (grey histogram) and NLC (black histogram) BMMs.  The 
cells were incubated at an m.o.i of 10 for 4 h, followed by washing and their analysis by flow 
cytometry.  The grey-filled histogram represents the 4 °C control.  (C) Surface expression 
levels of CD11b on Tg (gray histogram) and NLC (black histogram) BMMs, determined by 
flow cytometry. 
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Validation of cd11b-dnp38 transgene in the murine model 
 The cd11b-dominant negative p38 (cd11b-dnp38) mice were backcrossed to 
C3H/HeN background for > 10 generations.  To validate the expression of the transgene 
(Tg), we performed an RT-PCR with cDNA from lung, thymus and spleen.  The expression 
of the dnp38 transgene was identified in the tissues containing resident macrophages (Fig. 
3.6A).  We readily detected the expression of the transgene in BMMs (Fig. 3.6A).  The 
cd11b-dnp38 Tg mice developed normally and were born at the expected mendelian ratios 
with no signs of gross abnormalities.  The expression of the transgene did not affect 
macrophage generation or homeostatsis of macrophages, as determined by flow cytometric 
analysis of splenic F4/80+ in which the percentages of macrophages were similar between 
the Tg and NLC (Fig. 3.6B).  
To confirm that the insertion of the cd11b-dnp38 transgene is functional and inhibits 
the p38 MAP kinase signaling cascade, we analyzed the ability of BMM to produce the 
proinflammatory cytokines, TNF and IL-6.  Following stimulation with live B. burgdorferi, 
Tg macrophages produced significantly less TNF and IL-6 in response to B. burgdorferi, 
than NLC macrophages (Fig. 3.6C), in similar response to RAW264.7 cells treated with the 
p38 inhibitor SB203580 (47).  Overall, these results show that the expression of the transgene 
does not affect macrophage development and homeostasis but effectively inhibits the activity 
of the endogenous kinase. 
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Figure 3.6.  Expression of cd11b-dnp38 transgene. 
(A) Detection of mRNA in different tissues, plus bone marrow derived macrophages 
(BMDM) by RT-PCR.  (B) Percentage of F4/80+ cells in the spleens of Tg and NLC mice. 
Six to 8 week-old mice were analyzed for macrophage percentage by flow cytometry 
following staining with an anti-F4/80 mAb.  The analysis was performed on gated live cells 
according to their FSC vs. SSC profile.  (C) BMM were incubated with B. burgdorferi (m.o.i. 
= 25) for 6 hours and supernatants were analyzed by ELISA for cytokines levels.   
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Infection of cd11b-dnp38 transgenic mice results in higher bacterial burdens and 
reduced levels of ifng gene expression 
We assessed the development of joint and cardiac inflammation in the cd11b-dnp38 
Tg mice on the C3H/HeN background.  The mice were infected and analyzed after 2 weeks 
of infection.  No significant differences were observed in arthritis severity between Tg and 
NLC mice (Fig. 3.7A).  In contrast, the degree of carditis was significantly higher in the Tg 
animals compared to controls. (Fig. 3.7A & 3.7D) 
We determined the bacterial burdens in the skin and heart tissue.  Surprisingly, in 
spite of the identical ability to phagocytose B. burgdorferi, the number of spirochetes in the 
infected hearts of the Tg mice was significantly higher than in infected control mice (Fig. 
3.7B & Fig. 3.7C).  The antibody response was indistinguishable between the Tg and NLC 
infected mice (data not shown), indicating that the increased bacterial burden was not due to 
the generation of a deficient humoral response.   
The interplay between cells that infiltrate the heart during infection with B. 
burgdorferi dictates the inflammatory response.  The production of IFNγ induces the 
presentation of spirochetal antigens to iNKT by macrophages, enhances their phagocytic 
activity and results in the control of inflammation (51).  We therefore measured the 
production of IFNγ in the hearts of the infected mice by qRT-PCR.  The level of ifng mRNA 
in the infected hearts of the Tg mice was significantly reduced compared to NLC animals 
(Fig. 3.8A), indicating that the inability to control infection locally is the result of the 
deficient production of the macrophage-activating cytokine.  
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iNKT cells are major producers of IFNγ during cardiac infection; we therefore 
measured the infiltration of these cells in the infected tissue. We observed that the number of 
iNKT cells was significantly reduced in the hearts of the infected Tg mice (Fig. 3.8B). 
Monocyte chemotactic protein-1 (MCP-1), also known as CCL-2, is a chemokine that has 
been implicated in the translocation of iNKT cells to the lungs upon infection with 
Cryptococcus neomformans, in addition to tumors of diverse etiology, (115-117).  Because of 
the importance in chemotaxis of iNKT cells, we analyzed the level of expression of the mcp-
1 gene in the hearts of the Tg and NLC mice.  The level of mcp-1 expression was 
significantly reduced in the B. burgdorferi infected hearts of the dnp38 Tg animals compared 
to the NLC animals (Fig. 3.8C).  Moreover, Tg BMM secreted significantly lower basal 
levels of MCP-1 compared to the NLC in vitro, as well as in response to stimulation with live 
B. burgdorferi (Fig. 3.8D).  These results show that p38 MAP kinase regulates the expression 
of MCP-1, the infiltration of iNKT cells to the heart and production of the protective 
cytokine, IFNγ in response to B. burgdorferi. 
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Figure 3.7.  Infection of cd11b-dnp38 Tg mice with B. burgdorferi results in increased 
carditis. 
 
(A) Arthritis and carditis in 2 week-infected cd11b-dnp38 Tg and NLC mice.  Groups 
of mice were infected with B. burgdorferi and analyzed for joint and cardiac inflammation.  
The results represent the average ± SE of 5 mice per group in two independent experiments.  
B. burgdorferi levels in the ear (B) and heart (C) of the Tg and NLC infected mice.  (D) 
Representative hematoxylin and eosin histological sections of the hearts of the infected mice.  
The results represent the average ± SE of 5 mice per group in two independent experiments. 
  
	   54	  
 
 
 
Figure 3.8.  Decreased iNKT infiltration and IFNγ production in the hearts of infected 
Tg mice. 
qRT-PCR of Tg (black bars) and NLC (white bars) mouse heart mRNA for the 
quantification of (A) ifng and (B) vα14i-jα18 relative to actin expression.  (C) Relative 
expression of mcp-1 in the hearts of Tg and NLC infected mice.  mRNA was analyzed by 
qRT-PCR with primers specific for mcp-1 and the level of expression was determined 
relative to actin.  The results in A-C represent the average ± SE of 10 mice per group from 2 
independent experiments.  *, Student’s t test, p < 0.05. (D) Production of MCP-1 by Tg and 
NLC BMMs stimulated with B. burgdorferi (m.o.i.= 10) or left unstimulated.  The results 
represent the average ± SE of one experiment	  performed in triplicate and is representative of 
three experiments performed.  *, Student’s t test, p < 0.05. 
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CHAPTER IV 
CONCLUSIONS 
 
The study of the interaction between macrophages and B. burgdorferi has largely 
focused on the role played by Toll-like receptors and spirochetal lipoproteins.  In spite of its 
importance for controlling bacterial levels at site of inflammation (51) and generating the 
proinflammatory response of macrophages to the spirochete (33, 76, 85, 93), no receptor 
associated with phagocytosis of B. burgdorferi has been reported.  Here, we have identified 
the β2 integrin, CR3, as a receptor able to mediate the phagocytosis of B. burgdorferi both by 
murine macrophages and human monocytes.  
B. burgdorferi has developed mechanisms, known as CRASPs, to protect itself from 
complement mediated destruction.  Two of the CRASP proteins, CspA and OspE-related 
proteins, are expressed on the surface of the spirochete and bind complement factor H and H-
like (98, 100) and down regulate the alternative complement pathway.  Our findings 
demonstrate that serum enhances the internalization of B. burgdorferi in a C3-dependent 
manner and mutations to B. burgdorferi’s CspA and OspE result in loss of the protective 
mechanisms resulting in increased bacterial internalization by murine macrophages and 
human monocytes. 
Although CR3 expression alone confers phagocytic capacity to CHO cells for 
different pathogens and microbial products, including N. meningitidis (118), B. anthracis 
spores (62) and zymosan particles (119), this is not the case for B. burgdoferi.  In several 
cases, the phagocytic capacity of CR3 is enhanced by, but does not depend on, secondary 
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receptors.  For example, CD14 increases the phagocytic capacity of CR3 through the 
initiation of inside-out signals that induce the conversion of the integrin from a low to a high 
affinity conformation.  Classically CD14 requires the participation of TLRs, most 
predominantly TLR2 (62, 71, 72, 120), and involves PI3K activity (62, 72). However, CHO-
CR3/CD14 cells do not express a functional TLR2 (112) but nevertheless internalize the 
spirochete.  Consistent with the lack of a functional TLR2, B. burgdorferi internalization by 
CHO-CR3/CD14 cells is independent of MyD88 and PI3K activity.  Although activation of 
CR3 enhances the phagocytic capacity for the spirochetes, integrin activation is not required 
and MyD88 signals do not contribute to the activation of CR3 in response to B. burgdorferi.  
Even though a significant amount of phagocytosis of B. burgdorferi depends on MyD88-
derived signals, the internalization of the spirochete still occurs in the absence of the adaptor 
molecule (33, 110), suggesting that additional pathways are used by macrophages to 
phagocytose B. burgdorferi that are distinctly dependent of MyD88.  The identity of the 
receptor that mediates the MyD88-dependent internalization of the spirochete currently 
remains unknown.  Our observation of phagosomes containing the spirochete in the absence 
of CR3 strongly supports the theory of the MyD88-dependent receptor.  However, our data 
show that MyD88-independent phagocytosis involves, at least partly, the integrin CR3.  
Therefore, our results suggest the presence of other receptor(s) on macrophages that 
contribute to the internalization of the spirochete by macrophages, including those that are 
MyD88-dependent.  The two internalization pathways occurring during the internalization of 
B. burgdorferi are represented in Fig 4.1. 
Our results indicate that the role played by CD14 during CR3-mediated phagocytosis 
of the spirochete involves the localization of the integrin to cholesterol-rich membrane 
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microdomains, rather than the attachment of B. burgdorferi.  CD14 would facilitate the 
clustering of CR3 upon binding to B. burgdorferi permitting the initiation of signals that 
mediate its uptake.  In CHO-CR3 cells lacking CD14, the engagement of the C-lectin domain 
of CR3 is sufficient for the internalization of B. burgdorferi.  Whether CD14 is unique 
among GPI-anchored proteins in its ability to promote CR3-dependent phagocytosis of 
spirochetes remains to be addressed.  In the case of M. kansasii phagocytosis, for example, 
several GPI-anchored proteins besides CD14 mediate the uptake of the bacterium, including 
CD16b, CD66b or CD55 (102).  In fact, the lack of a noticeable defect in the phagocytic 
capacity of CD14-deficient macrophages to take up B. burgdorferi (85) suggests the 
redundant function of other GPI-anchored proteins in CR3-mediated phagocytosis of B. 
burgdorferi.   
Cardiac inflammation during infection with B. burgdorferi involves the migration and 
activation of macrophages and other cell types, including invariant NKT and T cells.  The 
production of IFNγ predominantly by iNKT and other cell types ameliorates inflammation 
through the activation of macrophages (121, 122).  The interaction of macrophages and 
iNKT cells involves feedback mechanisms between both cell types: macrophages present 
antigen to iNKT cells in the context of the antigen presenting molecule CD1d resulting in 
IFNγ production; in turn, IFNγ increases both the phagocytic activity of macrophages and the 
expression of CD1d, thereby increasing their capacity to present antigen to iNKT cells (121).  
Our results demonstrated that expression of a dominant negative p38 kinase did not alter the 
macrophages’ ability to internalize B. burgdorferi; however, infection of cd11b-dnp38 
transgenic mice reveled increased bacterial burdens and a reduction in infg gene expression.   
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The recruitment of iNKT cells to sites of inflammation or tumors occurs through the 
expression of chemokines.  Several studies have shown that the chemokine MCP-1 (CCL-2) 
regulates the infiltration of these cells to inflamed tissues and tumors (115, 116, 123), 
although MCP-1 has been classically associated with the migration of monocytes (124).  Our 
results show that in response to the spirochete, macrophages produce MCP-1 in a p38 MAP 
kinase-dependent manner.  Thus, dnp38 BMMs produce significantly lower levels of the 
chemokine in vitro.  Importantly, the expression of mcp-1 in the Tg infected hearts is 
significantly reduced compared to controls. Overall, our results support a model in which the 
colonization of B. burgdorferi-infected cardiac tissue by macrophages results in the 
production of MCP-1.  The chemokine induces the infiltration of iNKT cells, whereby 
macrophages are then able to present galactosyl diacylglycerol antigens from B. burgdorferi 
on the MHC class I-like molecule, CD1d to the iNKT cells (125) resulting in the production 
of the protective cytokine, IFNγ.  Our results show that p38 MAP kinase regulates a critical 
component in the development of cardiac inflammation. 
The infection of CD11b-deficient mice resulted in the development of increased 
murine Lyme carditis, thus associating the protective capacity of IFNγ (51, 126) controlling 
the number of spirochetes in the heart of infected mice.  Interestingly, stimulating CD11b-
deficient macrophages with B. burgdorferi significantly increases the production of the 
proinflammatory cytokine, TNF.  Importantly, infecting CD11b-deficient mice also leads to 
increased expression of the cytokine in the heart. The negative effect of CR3 on macrophage 
responses to E. coli and LPS has been recently reported and involves the degradation of 
MyD88 and TRIFF by the E3 ubiquitin ligase Cbl-b (108). In light of our results, we propose 
that the full complement of phagocytic receptors contribute to the internalization of the 
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bacterium, while at the same time establishing a balance of modulatory (both positive and 
negative) signals for cytokine production. This suggests that the proinflammatory output of 
phagocytic cells in response to B. burgdorferi is the result of the interplay between the 
different phagocytic receptors involved in the uptake of the spirochete that eventually 
determines the strength of the response.  
  Our results identify CR3 as a receptor able to mediate MyD88-independent 
phagocytosis of B. burgdorferi by murine macrophages and human monocytes.  The 
phagocytic activity of CR3 relies on the cooperation of the GPI-anchored protein CD14 and 
is independent both of MyD88 and inside-out signals, but does require the translocation of 
the integrin to cholesterol-rich membrane microdomains. Furthermore, phagocytosis of B. 
burgdorferi, mediated by CR3, results in the modulation of the proinflammatory response of 
macrophages.  Due to the importance of phagocytosis in the overall immune response to the 
spirochete and the control of infection, these data demonstrate that CR3 is a critical pathogen 
recognition receptor for B. burgdorferi. The identification of CR3 as a B. burgdorferi PRR 
helps clarify the mechanisms that drive not only the physical elimination of the bacteria 
during infection, but also the integration of the signals emanating from different receptors as 
a result of phagocytosis. 
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Figure 4.1.  Proposed model of internalization signaling. 
In response to B. burgdorferi, macrophages use at least two signaling pathways. One 
pathway is CR3-mediated phagocytosis that occurs independent of MyD88 signals and acts 
as a negative regulation of proinflammatory cytokine production.  An additional pathway 
results in the stimulation of the adaptor molecule, MyD88 and modulation of 
proinflammatory output of macrophages, mediated by an unidentified receptor. 
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CHAPTER V 
MATERIALS AND METHODS 
 
Mice 
C57Bl/6 mice and CD11b-deficient C57Bl/6 mice were purchased from Jackson 
laboratories and bred at UMass Amherst.  For the generation of cd11b-dnp38 transgenic 
mice, the cd11b-dnp38 MAP kinase transgene was constructed using the cd11b promoter 
extending from bp -1704 to +83 and included 83 bp of the 5’ untranslated region extending 
up to the ATG codon (a gift from Dr. Daniel G. Tenen), (127).  The plasmid also contains a 
2.1 kb fragment of the polyadenylation signals and intron sequences of the human growth 
hormone (128) (Fig. 3.5A).  The dnp38 gene was inserted between both sequences by 
digestion with Hind III and Xba I.  The transgenes were isolated by digestion with Hind III 
and Not I and purified by electroelution prior to microinjection into fertilized eggs.  The 
microinjected fertilized eggs were then implanted into pseudopregnant females.  Founders 
were then identified by slot blot using a Bam HI-Sac I 0.5 kb fragment from the human 
growth hormone gene (hGH) and PCR, using the primers (5’-AGG ATC CCA AGG CCC 
AAC TCC-3’ and 5’-CTC CTT AGT CTC CTC CTC TTA T-3’).  The transgenic mice have 
been backcrossed into the C3H/HeN background at least 10 generations to establish stable 
transgenic mouse lines.  The experiments described herein have been obtained using two 
lines of transgenic mice (171 and 178).  The Institutional Animal Care and Use Committee at 
UMass Amherst approved all procedures involving animals. 
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Bacteria 
The generation and characterization of Bb914, a virulent strain 297 B. burgdorferi 
clone which contains a constitutively expressed gfp reporter stably inserted into cp26, as been 
reported (129).  The bacteria were cultured in BSK-II (Sigma) medium at 34ºC and used at 
mid-log phase of growth. 
The CspA mutant and OspE overexpressing spirochetes were a gift from Darrin 
Akins.  In brief, the spirochetes were generated by initially inserting a streptomycin 
resistance cassette into cspA in B31 5A4NP1 then a gentamicin cassette and flaB-gfp on cp26 
(cspA -).  The mutation was complemented by inserting a gentamicin flaB-gfp and cpsA on 
cp26 (cspA +).  The cspA- stain was electroporated with a shuttle vector that was GFP+ and 
expressed OspE under the influence of the flgB promoter (OspE).  As a control, the shuttle 
vector containing only GFP was electroporated into the cspA- (Vector).  The bacteria strains 
were cultured in BSK-II (Sigma) and 40μg/ml gentamicin, 100μg/ml streptomycin and  
200μg/ml kanamycin at 34ºC and used at mid-log phase of growth. 
 
Generation of Bone Marrow Macrophages 
Bone marrow cells were collected from the femoral shafts and cultured in 20% L929-
conditioned RPMI 1640 supplemented with 10% FCS (Hyclone Thermo Scientific, Waltham, 
MA), 2.4 mM L-glutamine and 10% penicillin- streptomycin (Invitrogen, Carlsbad, CA) in 
100 mm x 15 mm petri dishes (Fisher Scientific, Pittsburgh, PA) for 8 days at 37 oC with 5% 
CO2.  Following incubation, non-adherent cells were eliminated and adherent macrophages 
scraped, counted and resuspended in serum-free RPMI medium 2 h prior to use.  
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Phagocytosis 
CHO-cells or macrophages (106/ml) were cultured in serum- and antibiotic-free 
medium with B914 B. burgdorferi at different m.o.i. for 4 or 6h, except where indicated.  The 
cells were then washed extensively and resuspended in PBS supplemented with 1% FCS and 
analyzed by flow cytometry using an LSR II flow cytometer (BD Biosciences) or were 
further prepared for microscopic analysis.  The data were analyzed with FlowJo for Mac, 
version 7.6 (Tree Star, Inc., Ashland, OR).  
 
In vivo Phagocytosis 
Mice were injected intraperitoneally with 107 B. burgdorferi.  The macrophages were 
harvested after 6 h by peritoneal lavage with 10 mL of ice-cold PBS, stained with mAb F4/80 
conjugated with allophycocyanin (APC) (eBioscience) in PBS, 1%FCS for 30 min at 4 °C 
and analyzed by flow cytometry. 
 
Inhibitor Treatments 
RAW264.7 and CHO-CR3/CD14 cells (106/ml) were preincubated for 1 hour with 50 
μM of a MyD88 inhibitory peptide (InvivoGen, San Diego, CA), 10 μM LY294002 (Cell 
Signaling Technology, Danvers, MA) or 2 μM wortmannin (Millipore, Temecula, CA), or 30 
min with 5 mM of methyl-β-cyclodextran (Sigma Aldrich) at 37°C in serum- and antibiotic- 
free medium, followed by incubation with B. burgdorferi (m.o.i. = 25) for 4 hours.  
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CD14 Blocking Assay 
 RAW264.7 and CHO-CR3/CD14 cells (106/ml) were preincubated for 1 hour with 10 
μg/ml of purified anti-mouse CD14, clone 4C1/CD14 (Biolegend, San Diego CA) or anti-
human CD14, clone M5E2 (BD Pharmingen), respectively.  For RAW264.7 cells, the isotype 
control Rat (DA) IgG2b, κ (BD Pharmingen) was used and the isotype control Mouse IgG2a, 
κ (Biolegend) was used for the CHO-CR3/CD14 cells.  Following the phagocytosis assay, 
spirochetal uptake was measured by flow cytometry, as described above. 
 
Microscopy 
To confirm phagocytosis, cells were examined by epifluorescence (ApoTome) and 
confocal microscopy.  Following incubation with bacteria, the cells were washed and fixed in 
3.7% paraformaldehyde for 7 minutes.  The cells were then permeabilized with 0.1% Triton-
X-100 for 5 min and washed. Following blocking of non-specific binding with 5% BSA for 
60 minutes, the cells were stained with rhodamine phalloidin to visualize the actin 
cytoskeleton for 30 minutes at 37 °C and DAPI to stain the nuclei (Invitrogen-Molecular 
Probes) for 5 minutes at 37 °C. The cells were mounted with Prolong Gold Anti-fade 
mounting reagent (Invitrogen- Molecular Probes).  Photomicrographs were taken using a 
Zeiss Axiovert 200M inverted microscope (Thornwood, NY) equipped with Apotome and a 
Hamamatsu Orca camera (Bridgewater, NJ).  When noted, the samples were analyzed with a 
Zeiss LSM 510 Meta Confocal System.  
In order to assess the localization of CD11b to lipid rafts, 5 x 104 RAW 264.7 cells 
were incubated with Bb914 (m.o.i 25) for 1 h.  The cells were incubated with CTxB the last 
20 min of the incubation period, washed and fixed.  The preparations were then incubated 
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with anti-CD11b conjugated to Alexa fluor 647 (M1/70) 2h at RT in the dark.  Upon 
extensive washing, the slides were mounted and analyzed by confocal microscopy.  
 
Cell fractionation by sucrose gradient ultracentrifugation 
We performed a detergent extraction method followed by sucrose gradient 
centrifugation (130), with a few modifications.  Briefly, 1 x 107 RAW 264.7 cells were 
stimulated with B. burgdorferi (m.o.i. 25) or left unstimulated for 1 h.  The cells were 
washed, resuspended in 200 μl of ice-cold lysis buffer (25 mM MES, pH 6.5, 150 mM NaCl, 
1% Triton X-100, 1 mM PMSF, 1 mM NaF, 1 mM Na3VO4 and a protein inhibitor cocktail 
(Sigma-Aldrich)) and disrupted by passage through a 25G syringe.  The cell lysate was 
mixed with an equal volume of 80% sucrose prepared in lysis buffer without TX-100, placed 
at the bottom of a discontinuous gradient (650 μl of 30% sucrose, 250 μl of 5% sucrose) and 
centrifuged at 200,000 xg for 20 h at 4 °C.  Ten fractions were recovered from the top and 
precipitated with trichloroacetic acid.  The samples were separated in a 10% polyacrylamide 
gel, transferred to nitrocellulose membranes and immunoblotted with anti-CD11b (M-19) 
and anti-CD14 (M-305) antibodies (Santa Cruz Biotechnology).  
 
Infection with B. burgdorferi 
Six to 8 week-old mice were infected by subcutaneous injection with 105 B. 
burgdorferi strain 297 in the midline of the back.  At 2 to 3 weeks of infection, which 
represent the acute phase of disease, the mice were sacrificed.  Arthritis and carditis were 
evaluated histologically in formalin-fixed sections processed for H&E staining. The joints 
were also decalcified.  The hearts were cut in half through bisections across the atria and 
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ventricles prior to sectioning.  Signs of arthritis were evaluated based on a combined 
assessment of histological parameters of B. burgdorferi-induced inflammation, such as 
exudation of fibrin and inflammatory cells into the joints, alteration in the thickness of 
tendons or ligament sheaths, as well as hypertrophy and hyperplasia of the synovium.  Signs 
of carditis were evaluated based on the cardiac inflammatory infiltrate, including the 
infiltration of connective tissue with macrophages at the base of the heart, including 
surrounding the aortic valve and the atria.  Carditis was scored on a scale of 0 (no 
inflammation), 1 (mild inflammation with less than two small foci of infiltration), 2 
(moderate inflammation with 2 or more foci of infiltration), or 3 (severe inflammation with 
focal and diffuse infiltration covering a large area).  Both joint and heart tissue sections were 
blindly examined.  
Determination of bacterial burdens 
The number of spirochetes in skin (ear) and heart tissue was determined by real-time 
PCR, using primers specific for the recA gene (5’- GTG GAT CTA TTG TAT TAG ATG 
AGG CTC TCG -3’ and 5’- GCC AAA GTT CTG CAA CAT TAA CAC CTA AAG -3’) 
(131) and the fluorescent DNA dye SYBR Green (Roche).  Total DNA was extracted by 
proteinase K-digestion followed by purification using the Qiagen tissue kit following the 
manufacturer’s instructions.  PCR conditions were: 40 cycles with denaturing (95 °C) and 
annealing/extension (60 °C) periods of 30 seconds. Under these conditions, we can detect 
around 10 spirochetes per pg of total DNA.  The number of spirochetes in each sample was 
standardized to mg of total DNA, as assessed by the use of primers corresponding to 
Glyceraldehyde 3-Phosphate Dehydrogenase (5’-CCA TCA CCA TCT TCC AGG AGC 
GAG-3’ and 5’-CAC AGT CTT CTG GGT GGC AGT GAT-3’) by real-time PCR (132). 
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qRT-PCR 
The relative gene expression in cardiac tissue was determined from total RNA 
extracted from the heart using the TRIzol reagent (Invitrogen, Carlsbad, CA) according to the 
manufacturer's instructions.  The RNA was treated with DNase I (Promega, Madison, WI) 
and  reverse transcribed using oligo dT primers (Invitrogen) and SuperScript II reverse 
transcriptase (RT) (Invitrogen).  The cDNA was amplified in an Mx3005P® QPCR System 
(Stratagene, La Jolla, CA), using the specific primers listed in Table. 5.1 with SYBR green-
containing reaction buffer (Roche, Nutley, NJ).  Relative expression of the gene was 
calculated relative to actin levels using the formula 2-ΔCt and fold induction of the genes were 
calculated relative to actin values using the 2-ΔΔCt method.   
 
 
Gene Forward Reverse 
actin GACGATGCTCCCCGGGCTGTATTC TCTCTTGCTCTGGGCCTCGTCACC 
tnf AGCCCACGTCGTAGCAAACCA C ATCGGCTGGCACCACTAGTTGGT 
vα14i-jα18 CACCCTGCTGGATGACACTGCC CTCCAAAATGCAGCCTCCCTAAG 
infg GCGTCATTGAATCACACC GGACCTGTGGGTTGTTGACC 
mcp-1 CGGAACCAAATGAGATCAGAACC GCTGCAGATTTACGGGTCAACTTC 
 
Table 5.1.  qRT-PCR specific primers 
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Analysis of CR3 affinity conformation 
0.5 x 106 RAW264.7, CHO-CR3 and CHO-CR3/CD14 cells were preincubated in 
media for 10 min at 37 °C, followed by incubation with Bb914 (m.o.i. 25) or 1 mM MnCl2 
for 30 min.  The cells were washed and stained with the mAb CBRM1/5 labeled with Alexa 
Fluor 647 for 45 min on ice.  After incubation, the cells were incubated on ice for 10 min 
with 1% paraformaldehyde, washed and analyzed by flow cytometry.  
 
Cytokine measurement 
The protein levels of MCP-1, IL-6 and TNF in supernatants produced by BMMs were 
determined by capture ELISA according to manufacturer’s recommendations with the BD 
OptEIA mouse MCP-1, IL-6 and TNF set II ELISA kits (BD Bioscience). 
Flow cytometry 
106 splenocytes were incubated 5 minutes with Fc block (BD pharmigen) followed by 
45 minutes at 4 °C with F4/80APC (BM8, eBioscience).  The cells were washed and 
resuspended in PBS 1%FCS for analysis by flow cytometry using an LSR II flow cytometer 
(BD Biosciences) and analyzed using FlowJo, version 7.6 (Tree Star, Inc.). 
To evaluate the surface expression in BMMs, 106 cells were incubated 5 minutes with 
Fc block followed by 45 minutes at 4 °C with TLR2PE (6C2, eBioscience), CD11bPE (M1/70, 
BD pharmigen) or CD1dPE (1B1, BD pharmigen).  The macrophages were washed and 
analyzed by flow cytometry. 
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Statistical Analysis 
The results are presented as means ± SE.  Significant differences between means were 
calculated with the Student’s t test.  The percentages of infected murine hearts as determined 
by qPCR were compared by Chi-squared analysis.  p values of 0.05 or less were considered 
statistically significant.   
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